Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse (Tenecteplase) in Korean Patients With Acute Myocardial Infarction

Trial Profile

Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse (Tenecteplase) in Korean Patients With Acute Myocardial Infarction

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2014

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Myocardial infarction
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 05 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top